Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 161 - 170 of 196 Results.

Popular Medicare Drug Plans Are Under Assault
John C. Goodman | Commentary | Mar. 10, 2014
Worse Than Death Panels: Cookbook Medicine
John C. Goodman | Commentary | Mar. 10, 2014
Prospects for Repealing PPACA’s Taxes on Medical Devices and Health Insurance
John R. Graham | Commentary | Jan. 16, 2014
How Congress Encourages Shortages of Cancer Drugs
John R. Graham | Commentary | Aug. 31, 2013
User Fees for Medical Devices: Third Time Lucky?
John R. Graham | Commentary | July 12, 2012
How Obama and Romney Will Make Me Healthier
Art Carden | Commentary | June 1, 2012
After Obamacare: More For The Supreme Court To Throw Out
John R. Graham | Commentary | Apr. 27, 2012
Feed the Beast: Renewing the Prescription Drug User Fee Act (PDUFA)
John R. Graham | Commentary | Mar. 9, 2012
What Are The Costs And Benefits of Patents for Prescription Drugs?
John R. Graham | Commentary | Jan. 25, 2012
Ask Not for Whom the Drug Tolls
Wendy McElroy | Commentary | Jan. 25, 2011






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL